Vaccination Mandates Loom

States Ramping Up for Biggest Vaccination Effort in U.S. History. Associated Press reported:

“The push could begin as early as next month, when federal officials say the first vaccine may be authorized for emergency use and immediately deployed to high-risk groups, such as health care workers.

“‘The calvary is coming,’ Dr. Anthony Fauci said Thursday on ABC’s ‘Good Morning America.” He said he hopes shots will be available to all Americans in April, May and June.”

Bill And Melinda Gates Are Giving Another $70 Million For Covid Vaccines. Forbes reported:

“Of the newly promised $70 million, $50 million will go to the Covax Advance Market Committee of Gavi, the Vaccine Alliance; the committee is a financing mechanism through which Gavi works to secure equitable access to COVID-19vaccines for 92 low- and middle-income countries. The donation will unlock an additional $16 million from the U.K. government, part of a commitment the country made to match some donations to the committee.”

HHS announces COVID-19 vaccine agreement with drug stores. Modern Healthcare reported:

“The goal eventually is to make getting a COVID-19 vaccine like getting a flu shot.

“Thursday’s agreement with major chain drug stores, grocery market pharmacies and other chains and networks covers about 3 in 5 pharmacies in all 50 states and U.S. territories such as Puerto Rico. It looks ahead to a time next spring when yet-to-be-approved vaccines will start to become available beyond priority groups such as health care workers and nursing home residents.”

Infected Again or Endless COVID? How the ‘Reinfection Phenomenon’ Could Impact Vaccines, Herd Immunity and Human Behavior. USA Today reported:

“No one knows how long the immune system can keep someone safe from COVID-19 after infection.

“Some diseases like measles are one and done. Once infected or vaccinated and the immune system typically provides protection forever. With other viruses, like the common cold — some of which are closely related to the coronavirus that causes COVID-19 — protection might not last a year, or even a season.”

How Pfizer Plans to Distribute Its Vaccine (It’s Complicated): Success will hinge on an untested network of governments, companies and health workers. New York Times reported:

“‘We have a lot of confusion at the state and the local health departments level, and a lot of concern about the nitty-gritty of deployment,’ said Dr. Saad B. Omer, the director of the Yale Institute for Global Health. ‘Which places, where to vaccinate, how to get the vaccine there, how to identify people in various risk groups, how to document, how to call back people for the second dose.’”

***

November 12, 2020

Boris Johnson to Meet Bill Gates to Plan National Vaccine Rollout With Pharma Giants. The Sun reported:

“A spokesperson for Downing Street said Mr. Gates, Mr. Johnson and bosses from pharmaceutical giants would discuss the [Prime Minister’s] ‘five point plan to stop future pandemics.’

“The plan was developed with the help of the Bill and Melinda Gates Foundation and the Trust, and aims to build a massive network of ‘zoonotic hubs’ to identify potentially dangerous viruses before they leap from animals to humans.”

Biden Coronavirus Task Force Doctor Says 4 to 6 Week Lockdown Could Control the Pandemic. Yahoo Finance reported:

“As the U.S. continues to set new daily record highs of coronavirus cases, at least one doctor on President-elect Joe Biden’s coronavirus task force is floating the idea of shutting down businesses in a lockdown that could last four to six weeks to control the spread of the pandemic.”

China Is Inoculating Thousands With Unapproved COVID-19 Vaccines. Why? NPR reported:

“One early November morning, a Peking duck cook, several construction workers and a software engineer patiently lined up outside a Beijing vaccine facility, awaiting their turn to be injected with a coronavirus vaccine still awaiting regulatory approval.”

Why COVID-19 Vaccine Policies Could Be Deadly for Older People, and the Age Discrimination Has Already Started. Marketwatch reported:

“‘When I read about the proposed ‘Fair Priority Model’ for allocating COVID-19vaccines in Science magazine recently — from University of Pennsylvania medical ethicist Ezekiel Emanuel and 18 others — I realized that ageist policies might just kill older people like me.’”

Live Music Stocks Soar on COVID-19 Vaccine Breakthrough. Billboard reported:

“Companies related to live entertainment, travel and tourism have been especially battered in 2020. News of the vaccine has helped push these companies’ share prices multiples above their pandemic low marks: Live Nation now trades 212.4% above its 2020 low of $21.70; American Airlines share price is 55.4% above its 2020; and Hilton Worldwide is 132.4% above its pandemic low after a 11.1% bump on Monday morning.”

Fauci: Coronavirus Won’t Be a Pandemic For ‘a Lot Longer’ Thanks to Vaccines. The Hill reported:

“Anthony Fauci said Thursday the global coronavirus outbreak will not be a pandemic for ‘a lot longer’ because of the development of vaccines, striking a hopeful note even as the situation worsens in the short term.

“’Certainly it’s not going to be pandemic for a lot longer because I believe the vaccines are going to turn that around,’ Fauci said at an event hosted by the think tank Chatham House.”

Brazil Health Regulator Allows Resumption of China COVID Vaccine Trials. The Guardian reported:

“Brazil’s health regulator has allowed resumption of late-stage clinical trials for China’s Sinovac COVID-19 vaccine, which had been suspended due to a study subject’s death that was registered in Sao Paulo as a suicide.”

Moderna Hits COVID-19 Case Goal for Vaccine Candidate, Results Imminent. Boston Herald reported:

“The surge in coronavirus cases across Moderna vaccine trial sites in the U.S. will now allow the Cambridge-based company to complete the analysis of its mRNA vaccine candidate.

Coronavirus Vaccine: Eu Seals Deal With Biontech, Pfizer to Secure Doses. EIN News reported:

“The European Commission approved a contract with German pharmaceutical firm BioNTech and their U.S. partner Pfizer on Wednesday, guaranteeing that the bloc will receive millions of doses of their experimental coronavirus vaccine.

“After locking down the details of the deal on Tuesday, Commission President Ursula von der Leyen said the bloc hopes to ‘deploy it quickly, everywhere in Europe.’”